Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$575M |
| 2 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$232M |
| 3 |
Charles Schwab
SCHW
|
+$197M |
| 4 |
Boston Scientific
BSX
|
+$190M |
| 5 |
Clarivate
CLVT
|
+$142M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.19B |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$694M |
| 4 |
AstraZeneca
AZN
|
+$679M |
| 5 |
Microsoft
MSFT
|
+$555M |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Financials | 10.95% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Healthcare | 8.57% |
| 5 | Communication Services | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Cadence Bank
CADE
$6.87B
| $623K | ﹤0.01% |
20,906
-72,452
| -78% | -$2.16M |
|
2702
Dime Community Bancshares
DCOM
$1.35B
| $621K | ﹤0.01% |
19,008
-260
| -1% | -$8.49K |
|
2703
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.43B
| $619K | ﹤0.01% |
8,221
-5,750
| -41% | -$433K |
|
2704
Griffon
GFF
$3.53B
| $619K | ﹤0.01% |
25,177
-4
| -0% | -$98 |
|
2705
Ichor Holdings
ICHR
$566M
| $618K | ﹤0.01% |
15,047
-401
| -3% | -$16.5K |
|
2706
Scholastic
SCHL
$683M
| $618K | ﹤0.01% |
17,328
-211
| -1% | -$7.53K |
|
2707
Compañía de Minas Buenaventura
BVN
$5.03B
| $615K | ﹤0.01% |
90,963
+6,954
| +8% | +$47K |
|
|
FPAC.U
2708
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
| $615K | ﹤0.01% |
58,500
-28,900
| -33% | -$304K |
|
2709
Photronics
PLAB
$1.38B
| $614K | ﹤0.01% |
45,076
-18,989
| -30% | -$259K |
|
2710
Collegium Pharmaceutical
COLL
$1.12B
| $613K | ﹤0.01% |
31,049
+5,902
| +23% | +$117K |
|
2711
AnaptysBio
ANAB
$554M
| $612K | ﹤0.01% |
22,550
-54,028
| -71% | -$1.47M |
|
2712
Inogen
INGN
$225M
| $611K | ﹤0.01% |
14,191
+1,038
| +8% | +$44.7K |
|
2713
Liberty Latin America Class A
LILA
$1.58B
| $611K | ﹤0.01% |
46,685
-65,457
| -58% | -$857K |
|
2714
United Parks & Resorts
PRKS
$2.78B
| $611K | ﹤0.01% |
11,046
+1,969
| +22% | +$109K |
|
2715
WaFd
WAFD
$2.45B
| $610K | ﹤0.01% |
17,790
-4,573
| -20% | -$157K |
|
2716
Goosehead Insurance
GSHD
$2.05B
| $609K | ﹤0.01% |
3,996
+73
| +2% | +$11.1K |
|
2717
Preferred Bank
PFBC
$1.14B
| $607K | ﹤0.01% |
9,104
-6,411
| -41% | -$427K |
|
2718
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$643M
| $605K | ﹤0.01% |
9,905
-6,507
| -40% | -$397K |
|
2719
iShares US Energy ETF
IYE
$1.16B
| $601K | ﹤0.01% |
21,269
-5,540
| -21% | -$157K |
|
2720
Wabash National
WNC
$450M
| $601K | ﹤0.01% |
39,757
-11,278
| -22% | -$170K |
|
2721
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.47B
| $599K | ﹤0.01% |
42,072
-26,522
| -39% | -$378K |
|
2722
Vanguard Long-Term Corporate Bond ETF
VCLT
$7.46B
| $598K | ﹤0.01% |
5,661
-179
| -3% | -$18.9K |
|
2723
iShares Core S&P US Growth ETF
IUSG
$25.3B
| $597K | ﹤0.01% |
5,828
-3,571
| -38% | -$366K |
|
|
INVX
2724
Innovex International, Inc.
INVX
$1.16B
| $597K | ﹤0.01% |
23,730
-7,384
| -24% | -$186K |
|
2725
Arcutis Biotherapeutics
ARQT
$2.06B
| $596K | ﹤0.01% |
24,936
-36,483
| -59% | -$872K |
|